These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23392469)

  • 61. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
    Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
    AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
    Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
    Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
    [TBL] [Abstract][Full Text] [Related]  

  • 63. T-cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication.
    Erikstrup C; Kronborg G; Lohse N; Ostrowski SR; Gerstoft J; Ullum H
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):303-10. PubMed ID: 20048679
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women.
    Mikyas Y; Aziz N; Harawa N; Gorre M; Neagos N; Nogueira M; Wafer D; Dillon M; Boyer PJ; Bryson YJ; Plaeger S
    J Reprod Immunol; 1997 Jun; 33(2):157-70. PubMed ID: 9234214
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
    Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
    Front Immunol; 2021; 12():688886. PubMed ID: 34135912
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection.
    Casetti R; Pinnetti C; Sacchi A; De Simone G; Bordoni V; Cimini E; Tumino N; Besi F; Viola D; Turchi F; Mazzotta V; Antinori A; Martini F; Ammassari A; Agrati C
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):338-344. PubMed ID: 28418988
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
    Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
    Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy.
    Behrens NE; Wertheimer A; Klotz SA; Ahmad N
    PLoS One; 2018; 13(6):e0199101. PubMed ID: 29897981
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
    Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
    Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
    Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
    J Virol; 2019 May; 93(10):. PubMed ID: 30814287
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients--effects of antiretroviral therapy.
    Colle JH; Moreau JL; Fontanet A; Lambotte O; Joussemet M; Jacod S; Delfraissy JF; Thèze J
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):277-85. PubMed ID: 16810123
    [TBL] [Abstract][Full Text] [Related]  

  • 78. T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness.
    Downey JS; Attaf M; Moyle G; Gazzard B; Gotch F; Imami N
    AIDS; 2011 Oct; 25(16):1981-6. PubMed ID: 21811141
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment.
    Monsalvo M; Vallejo A; Fontecha M; Vivancos MJ; Vizcarra P; Casado JL
    Int J STD AIDS; 2019 Jun; 30(7):656-662. PubMed ID: 30961467
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.